,,ii #aagth ,,congress #b;d ,session ,s4 #daea ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,may #e1 #bjbb,mr4 ,grassley 7for himself1 ,mrs4 ,feinstein1 ,mr4 ,cornyn1 and ,ms4 ,hassan7 introduced the following bill2 which was read twice and referred to the ,committee on the ,judiciary ,a ,,bill ,to amend the ,controlled ,substances ,act to prohibit certain acts related to fentanyl1 analogues of fentanyl1 and counterfeit substances1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,stop ,pills ,that ,kill ,act4 #b4 ,definition ,in this ,act1 the term counterfeit fentanyl or methamphetamine substance means a substance that-- 7#a7 contains fentanyl1 any analogue of fentanyl1 or methamphetamine2 and 7#b7 is marketed1 sold1 or falsely bears the trademark1 trade name1 or other identifying mark1 imprint1 number1 or any likeness thereof of another product4 #c4 ,prohibited acts ,section #djc7;d77#b7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hdc7;d77#b77 is amended1 in the matter preceding subparagraph 7,a71 by inserting 1 fentanyl1 an analogue of fentanyl1 or a counterfeit substance after methamphetamine4 #d4 ,directive to the ,united ,states ,sentencing ,commission ,the ,united ,states ,sentencing ,commission shall review and amend1 if appropriate1 the sentencing guidelines in accordance with section #iid of title #bh1 ,united ,states ,code1 to provide for a #d-level enhancement for a defendant who knowingly misrepresented as either a prescription or over-the-counter medication in pill or tablet form a counterfeit or otherwise adulterated pill or tablet that contained a detectable amount of fentanyl1 or a fentanyl analogue1 or methamphetamine4 #e4 ,comprehensive plan ,not later than #ahj days after the date of enactment of this ,act1 the ,administrator of the ,drug ,enforcement ,administration shall establish and implement an operation and response plan to address counterfeit fentanyl or methamphetamine substances that includes-- 7#a7 strategies to enable and empower ,federal law enforcement efforts to investigate and seize counterfeit fentanyl or methamphetamine substances2 7#b7 specific ways that education and prevention efforts to stop the use of counterfeit fentanyl or methamphetamine substances will be increased1 including how-- 7,a7 ongoing efforts1 such as ,operation ,engage1 are effective in increasing education and prevention2 and 7,b7 how the efforts described in subparagraph 7,a7 are tailored to youth and teen access2 and 7#c7 an audit of current campaigns1 including the ,one ,pill ,can ,kill campaign1 on counterfeit fentanyl or methamphetamine substances1 including a review of data and other available information on how such campaigns can be tailored1 adjusted1 or improved to better address the flow of counterfeit fentanyl or methamphetamine substances4 #f4 ,report to ,congress 7a7 ,report ,not later than #a year after the date of enactment of this ,act1 and every year thereafter1 the ,attorney ,general1 in consultation with the ,administrator of the ,drug ,enforcement ,administration and ,director of the ,office of ,national ,drug ,control ,policy1 shall submit to ,congress a report on information regarding the collection and prosecutions of counterfeit fentanyl or methamphetamine substances4 7b7 ,contents ,the report required under subsection 7a7 shall include the following3 7#a7 ,data on the aggregate number of counterfeit fentanyl or methamphetamine substances seized and collected by ,federal law enforcement agencies4 7#b7 ,a breakdown on how many counterfeit fentanyl or methamphetamine substances are in pill form4 7#c7 ,a breakdown on which illicit substances are present in the counterfeit fentanyl or methamphetamine substances that are in pill form4 7#d7 ,data outlining where and when counterfeit fentanyl or methamphetamine substances were seized4 7#e7 ,data on the charges filed against those manufacturing1 distributing1 or dispending1 or possessing with the intent to distribute or dispense a counterfeit fentanyl or methamphetamine substance1 particularly in pill form1 pursuant to paragraph 7#a7 or 7#b7 of section #dja7;a7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hda7;a771 unless disclosure of such data would require unsealing an indictment or would undermine investigations and charges brought by the ,department of ,justice4 7#f7 ,data on the convictions and sentences against those who are found guilty under paragraph 7#a7 or 7#b7 of section #dja7;a7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hda7;a77 as it pertains to counterfeit fentanyl or methamphetamine substances1 particularly those in pill form4 7#g7 ,any prevention measures that the ,department of ,justice1 ,drug ,enforcement ,administration1 or ,office of ,national ,drug ,control ,policy are undertaking to limit and reduce the spread of counterfeit fentanyl or methamphetamine substances in pill form1 including ongoing public awareness campaigns4